| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |